dichloroplatinum(2+) 4-bromopiperidin-1-ide 4-bromo-2H-pyridin-1-ide (1:1:1)
dichloroplatinum(2+) 4-bromopiperidin-1-ide 4-bromo-2H-pyridin-1-ide (1:1:1)(69811-99-0)
- Name: dichloroplatinum(2+) 4-bromopiperidin-1-ide 4-bromo-2H-pyridin-1-ide (1:1:1)
- Synonyms:Pyridine,4-bromo-, platinum complex; NSC 129206
- Molecular Formula:C10H8 Br2 Cl2 N2 Pt
- Molecular Weight:588.0296
- CAS Registry Number:69811-99-0
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.69811-99-0 Platinum,bis(4-bromopyridine)dichloro-, (SP-4-2)- (9CI)
Assay:90%,98% Appearance:detailed see specifications Package:according to the clients requirement Storage:Store in dry, dark and ventilated place. Transportation:by air or by sea Application:Used in Synthesis, Pharmaceuticals and other fields
Min. Order:1Kilogram
Supplier:Dayang Chem (Hangzhou) Co.,Ltd. [
China (Mainland)] 
Assessed
SupplierTel:+86-571-88938639
Address:9/F, Unit 2 Changdi Torch Building, 259# WenSan Road, Xihu District, Hangzhou City 310012, P.R.China
- Contact Suppliers
CAS No.69811-99-0 Platinum,bis(4-bromopyridine)dichloro-, (SP-4-2)- (9CI) cas 69811-99-0
Assay:99%min Appearance:white crystalline powder Package:25KG drum Storage:Store in dry, dark and ventilated place Transportation:by air, by sea, by express Application:intermediate
Min. Order:0
Supplier:Hangzhou Fandachem Co.,Ltd [
China (Mainland)] 
Premium
SupplierTel:+86-571-28800458
Address:Room 5010, No.9 YanAn Road,Hangzhou,Zhejiang,China
- Contact Suppliers
Other Product
- 26141-02-6/1,3-Benzenedicarboxylic acid, polymer with 1,3-dihydro-1,3-dioxo-5-isobenzofurancarboxylic acid, hexanedioic acid and 1,2-propanediol
- 88655-17-8/1-[2-(4-methoxyphenyl)ethyl]pyrimidine-2,4(1H,3H)-dione
- 77401-25-3/1,6-dimethyl-4-(propan-2-yl)naphthalene-2,7-diol
- 54340-58-8/Meptazinol
- 87048-95-1/1-{2,5-bis[3-(propan-2-ylamino)propoxy]phenyl}ethanone
- 14173-37-6/2-amino-8-(4-nitrophenyl)-3,7-dihydro-6H-purin-6-one
- 26750-81-2/Alibendol
- 50663-77-9/1,1'-[(carboxyamino)phosphinylidene]bis-
- 327177-98-0/Chromate(3-), bis(3-((6-amino-1,4-dihydro-2-(((4-((2-hydroxy-1-naphthalenyl)azo)phenyl)sulfonyl)amino)-4-(oxo-kappaO)-5-pyrimidinyl)azo-kappaN1)-4-(hydroxy-kappaO)-5-nitrobenzenesulfonato(3-))-, sodium triethanolamine salts
- 54119-35-6/2-[2-(dibenzylamino)ethylamino]ethanol
- 59708-23-5/4-[(1E)-3-methyl-3-(propan-2-yl)triaz-1-en-1-yl]benzamide
- 83829-32-7/auramycin F
- 2140-58-1/[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-phosphinic acid
- 155666-65-2/D-Ribitol,1-C-(7-aminoisothiazolo[4,5-d]pyrimidin-3-yl)-1,4-anhydro-, (1S)-
- 115398-79-3/2-({1-[(dimethylamino)methyl]-1H-benzimidazol-2-yl}methyl)-1H-isoindole-1,3(2H)-dione
- 43029-39-6/3-methyl-6-(2-phenylvinyl)[1,2,4]triazolo[3,4-b][1,3,4]thiadiazole
- 126770-34-1/Butanoic acid,2-methyl-,5-(acetyloxy)-6,7-bis(benzoyloxy)octahydro-4-hydroxy-2,2,5a,9-tetramethyl-2H-3,9a-methano-1-benzoxepin-10-ylester (9CI)
- 94279-04-6/2-isobutoxycyclohexan-1-ol
- 68084-03-7/DI-ISOAMYLTHIOMALATE
- 69811-99-0/dichloroplatinum(2+) 4-bromopiperidin-1-ide 4-bromo-2H-pyridin-1-ide (1:1:1)
- 4775-07-9/1-(diaminomethylidene)-2-(5-thiophen-2-yl-1H-pyrazol-3-yl)guanidine
- 31542-63-9/1,3-Dipropyl-7-methylxanthine
- 66871-59-8/1-(3,5-dimethylphenyl)-3-(methylcarbamimidoyl)urea hydrochloride
- 338957-99-6/nomilin glucoside
- 61847-54-9/Yoracryl Red RL
- 120342-36-1/ethyl 1-{2-hydroxy-3-[(1-methylethyl)amino]propyl}-5-methoxy-2-methyl-1H-indole-3-carboxylate hydrochloride
- 143433-71-0/sodium (6R,7R)-3-[(acetyloxy)methyl]-7-({[1-(3-bromophenyl)cyclopentyl]carbonyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- 30294-43-0/2-[(E)-2-(5-nitrofuran-2-yl)ethenyl]-4,5,6,7-tetrahydro-1,3-benzoxazole
- 70851-63-7/1,1'-Methylenebis[4,5-dihydroxy-3-(2-hydroxyethyl)-2-imidazolidinone]
- 103883-03-0/EPICATECHIN-(4BETA->8:2BETA-O-7) CATECHIN